12th Sep 2018 17:37
LONDON (Alliance News) - Drug development company Proteome Sciences PLC said Non-Executive Director Martin Diggle purchased 601,582 shares at a price of 3.60 pence per share on Tuesday.
Following this GBP21,657 transaction, Diggle now holds 59.3 million shares in Proteome, reflecting a 20% stake in the company.
Shares in Proteome closed trading down 5.0% at 3.63 pence on Wednesday.
Related Shares:
Proteome